A Nano-Pharmaceutical Formula of Quercetin Protects from Cardiovascular Complications Associated with Metabolic Syndrome

• Päätekijät: Osama A. A. Ahmed (Tekijä), Noura A. Hassan (Tekijä), Ahmad S. Azhar (Tekijä), Mahmoud M. El-Mas (Tekijä), Hany M. El-Bassossy (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2021-08-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Metabolic syndrome (MetS) is closely associated with the development of cardiovascular diseases. We recently developed a nano-preparation of the flavonoid quercetin (QU) in a self-nanoemulsifying drug delivery system (SNEDDS). The latter comprised a mixture composed of pumpkin seed oil, D-α-Tocopher...